Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Brain Research

• Publication date

  1987-12-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/0006-8993(87)91628-3PMID 3322505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat

  2004cited by this paper
• Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens

  2004cited by this paper
• CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.

  1987cited by this paper
• Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus.

  1986cited by this paper
• Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain

  1985cited by this paper
• An Excitant Amino Acid Projection from the Medial Prefrontal Cortex to the Anterior Part of Nucleus Accumbens in the Rat

  1985cited by this paper
• Muscle relaxant action of excitatory amino acid antagonists.

  1985cited by this paper
• Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid.

  1983cited by this paper
• Pharmacology of excitatory amino acid transmitters.

  1981cited by this paper
• Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP.

  1981cited by this paper
• Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain.

  1981cited by this paper
• Excitatory amino acid transmitters.

  1981cited by this paper
• From motivation to action: functional interface between the limbic system and the motor system.

  1980cited by this paper
• STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS

  1979cited by this paper

• Inactivation of NMDAR and CaMKII signaling within the prelimbic cortex blocks incubated cocaine- and sucrose-craving

  2025cites this paper
• Animals with a schizophrenia-like phenotype are differentially sensitive to the motivational effects of cannabinoid agonists in conditioned place preference.

  2014cites this paper
• Role of the Transcription Factor CREB in the NMDA Receptor Antagonist-Induced Attention Deficits

  2011cites this paper
• Prefrontal stimulation of GABAA receptors counteracts the corticolimbic hyperactivity produced by NMDA antagonists in the prefrontal cortex of the rat

  2011cites this paper
• Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models.

  2009cites this paper
• Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity

  2008cites this paper
• Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex.

  2007cites this paper
• A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice

  2005cites this paper
• Effects of N-methyl-d-aspartate antagonism on spatial learning in mice

  2005cites this paper
• Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

  2005cites this paper
• Memory deficits induced byγ-l-glutamyl-l-aspartate andd-2-amino-5-phosphonovalerate in a Y-maze avoidance task: relationship to NMDA receptor antagonism

  2005cites this paper
• The Serotonin 5-HT2A Receptors Antagonist M100907 Prevents Impairment in Attentional Performance by NMDA Receptor Blockade in the Rat Prefrontal Cortex

  2004cites this paper
• Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine

  2003cites this paper
• Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission.

  2002cites this paper
• Effects of olfactory bulbectomy on NMDA receptor density in the rat brain:.

  2001cites this paper
• Competitive and noncompetitive NMDA antagonist effects in rats trained to discriminate lever-press counts.

  2001cites this paper
• Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.

  1998influential citation
• Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.

  1997cites this paper
• Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.

  1996cites this paper
• MK-801 alters the GABAA receptor complex and potentiates flurazepam's antiseizure efficacy.

  1995cites this paper
• Computerized measurement of MK-801-elicited popping and hyperactivity in mice.

  1995cites this paper
• Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex.

  1995cites this paper
• Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice.

  1995cites this paper
• Association of nerve growth factor mRNA levels with MK‐801‐induced explosive behaviors in mice

  1995cites this paper
• Modulation of N-methyl-D-aspartate (NMDA) antagonist-induced darting behaviour by the peptidomimetic PAMTA.

  1995cites this paper
• Investigation of the Distribution of EAB 515 to Cortical ECF and CSF in Freely Moving Rats Utilizing Microdialysis

  1994cites this paper
• Excitatory amino acids: implications for psychiatric disorders research.

  1994cites this paper
• Effects of stimulation of the frontoparietal cortex and parafascicular nucleus on locomotion in rats.

  1994cites this paper
• Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice.

  1994cites this paper
• Measurement of an explosive behavior in the mouse, induced by MK-801, a PCP analogue.

  1993cites this paper
• Polyamines inhibit N-methyl-D-aspartate antagonist-induced darting behavior in the rat prefrontal cortex.

  1992cites this paper
• Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice.

  1991cites this paper
• Metabolic effects of neuropeptide Y injected into the sulcal prefrontal cortex.

  1990cites this paper
• Intracerebroventricular injection of kynurenic acid, but not kynurenine, induces ataxia and stereotyped behavior in rats.

  1990cites this paper
• Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.

  1989cites this paper
• Ethanol inhibits NMDA-activated ion current in hippocampal neurons.

  1989cites this paper
• Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons.

  1989cites this paper
• Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.

  1989cites this paper
• Psychotropic effects of diethyl glutamate in mice

  1989cites this paper
• A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

  1989cites this paper